These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11939264)

  • 1. Risk of etoposide-related acute myeloid leukemia in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Imashuku S; Teramura T; Kuriyama K; Kitazawa J; Ito E; Morimoto A; Hibi S
    Int J Hematol; 2002 Feb; 75(2):174-7. PubMed ID: 11939264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Kitazawa J; Ito E; Arai K; Yokoyama M; Fukayama M; Imashuku S
    Med Pediatr Oncol; 2001 Aug; 37(2):153-4. PubMed ID: 11496359
    [No Abstract]   [Full Text] [Related]  

  • 3. [Report of a case with secondary acute promyelocytic leukemia after therapy for hemophagocytic lymphohistiocytosis and review of literature].
    Su Y; Zhou X; Zhang L; Zhang R
    Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):938-42. PubMed ID: 24495767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Imashuku S; Kuriyama K; Teramura T; Ishii E; Kinugawa N; Kato M; Sako M; Hibi S
    J Clin Oncol; 2001 May; 19(10):2665-73. PubMed ID: 11352958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.
    Kollmannsberger C; Beyer J; Droz JP; Harstrick A; Hartmann JT; Biron P; Fléchon A; Schöffski P; Kuczyk M; Schmoll HJ; Kanz L; Bokemeyer C
    J Clin Oncol; 1998 Oct; 16(10):3386-91. PubMed ID: 9779717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol.
    Lee JS; Kang JH; Lee GK; Park HJ
    J Korean Med Sci; 2005 Apr; 20(2):209-14. PubMed ID: 15831988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center.
    Imashuku S; Kuriyama K; Sakai R; Nakao Y; Masuda S; Yasuda N; Kawano F; Yakushijin K; Miyagawa A; Nakao T; Teramura T; Tabata Y; Morimoto A; Hibi S
    Med Pediatr Oncol; 2003 Aug; 41(2):103-9. PubMed ID: 12825212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group.
    Kogawa K; Sato H; Asano T; Ohga S; Kudo K; Morimoto A; Ohta S; Wakiguchi H; Kanegane H; Oda M; Ishii E
    Pediatr Blood Cancer; 2014 Jul; 61(7):1257-62. PubMed ID: 24535916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Shiraishi A; Ohga S; Doi T; Ishimura M; Takimoto T; Takada H; Miyamoto T; Abe Y; Hara T
    Pediatr Blood Cancer; 2012 Aug; 59(2):265-70. PubMed ID: 22183955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Imashuku S; Teramura T; Tauchi H; Ishida Y; Otoh Y; Sawada M; Tanaka H; Watanabe A; Tabata Y; Morimoto A; Hibi S; Henter JI
    Haematologica; 2004 Feb; 89(2):183-8. PubMed ID: 15003893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute myeloid leukemia following etoposide therapy for EBV-associated hemophagocytic lymphohistiocytosis: a case report and a brief review of the literature.
    Pan H; Feng DN; Song L; Sun LR
    BMC Pediatr; 2016 Jul; 16():116. PubMed ID: 27473573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary acute myelogenous leukemia following safe exposure to etoposide.
    Stine KC; Saylors RL; Sawyer JR; Becton DL
    J Clin Oncol; 1997 Apr; 15(4):1583-6. PubMed ID: 9193356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement for etoposide in the initial treatment of Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis.
    Song Y; Wang Y; Wang Z
    Br J Haematol; 2019 Sep; 186(5):717-723. PubMed ID: 31115044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Histiocyte Society.
    Imashuku S; Hibi S; Ohara T; Iwai A; Sako M; Kato M; Arakawa H; Sotomatsu M; Kataoka S; Asami K; Hasegawa D; Kosaka Y; Sano K; Igarashi N; Maruhashi K; Ichimi R; Kawasaki H; Maeda N; Tanizawa A; Arai K; Abe T; Hisakawa H; Miyashita H; Henter JI
    Blood; 1999 Mar; 93(6):1869-74. PubMed ID: 10068659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.
    RamaChandran S; Ariffin H
    Pediatr Blood Cancer; 2009 Sep; 53(3):488-90. PubMed ID: 19434733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus (EBV)-induced B-cell proliferative disorder after chemotherapy in a patient with hemophagocytic lymphohistiocytosis with associated EBV-induced T-cell proliferation.
    Suzumiya J; Ohshima K; Kanda M; Kumagawa M; Nagano M; Hirata M; Nawa Y; Tamura K; Kikuchi M
    Leuk Lymphoma; 2000 May; 37(5-6):593-604. PubMed ID: 11042520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Cytokine Profile during Initial Treatment of Pediatric Hemophagocytic Lymphohistiocytosis Associated with Epstein-Barr Virus.
    Ueda T; Itabashi T; Yamanishi S; Tanabe Y; Migita M; Itoh Y
    J Nippon Med Sch; 2020 Jul; 87(3):166-170. PubMed ID: 32238729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal observation and outcome of nonfamilial childhood haemophagocytic syndrome receiving etoposide-containing regimens.
    Chen JS; Lin KH; Lin DT; Chen RL; Jou ST; Su IJ
    Br J Haematol; 1998 Dec; 103(3):756-62. PubMed ID: 9858227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
    Ohga S; Kudo K; Ishii E; Honjo S; Morimoto A; Osugi Y; Sawada A; Inoue M; Tabuchi K; Suzuki N; Ishida Y; Imashuku S; Kato S; Hara T
    Pediatr Blood Cancer; 2010 Feb; 54(2):299-306. PubMed ID: 19827139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of cell-free Epstein-Barr virus genome copy number in patients with EBV-associated hemophagocytic lymphohistiocytosis.
    Teramura T; Tabata Y; Yagi T; Morimoto A; Hibi S; Imashuku S
    Leuk Lymphoma; 2002 Jan; 43(1):173-9. PubMed ID: 11908724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.